Hyperactive Chemotaxis Contributes to AntiTNFα Treatment Resistance in Inflammatory Bowel Disease
- Payton Yau (Speaker)
Activity: Talk, evidence or presentation types › Oral presentation
Activity: Talk, evidence or presentation types › Oral presentation